J2B株式会社 has joined the HIVELAB Group through the transfer of existing shares. It will expand its business by drawing on its creative production capabilities and knowledge of the Japanese market in collaboration with HIVELAB's AI solutions and platform development capabilities.
J2B株式会社 joined the HIVELAB Group through an M&A transaction involving the transfer of existing shares. Following the transaction, it aims to expand globally, starting with Japan and South Korea, by combining J2B's marketing capabilities with HIVELAB's AI technology and platform development capabilities.
After the M&A, the management teams of J2B, HIVELAB and Keystone Marketing Company will participate in one another's operations, with the aim of strengthening coordination across management, production and sales. The companies will establish an integrated support structure covering everything from planning AI production to platform development and local marketing execution.
As a specific business collaboration, the companies aim to build an AI production framework by combining HIVELAB's AI production automation solution, AVIKO, with J2B's video-generation solution, MYSACCA. They will provide production and platform development as an integrated offering to address challenges in the Japanese market.
They will also jointly promote support for Japanese companies expanding overseas and South Korean companies entering Japan by leveraging their global customer bases, and will expand new proposals that draw on the strengths of Japan and South Korea.